Gambia launches inquiry into children deaths linked to India syrups
Gambia suspends "license of the suspected... importer" following deaths of 66 children in the small West African country that WHO says are possibly linked to four cough and cold syrups made by Maiden Pharmaceuticals in India.
A member of the Gambian Red Cross looks through sacks of collected cough syrups in Banjul on October 06, 2022.
Police in The Gambia have announced an investigation into the deaths of dozens of children, amid growing concern over imported medicines.
Following the deaths of 66 children, most from acute kidney failure, police said in a statement on Saturday they were putting senior officers on the investigation.
India is investigating cough syrups made by a local pharmaceutical company after the World Health Organisation said they could be responsible for the deaths.
President Adama Barrow authorised the health authorities "to suspend the license of the suspected... importer" involved in the case, his office said on Saturday evening.
The Foreign Ministry was to communicate "his government's most profound concern" to the Indian embassy, it added.
Barrow on Friday promised to boost health measures including better quality control over imported medicines.
He said the government would leave "no stone unturned" to get to the bottom of the incident.
READ MORE: WHO probes India syrups after dozens of children die in Gambia
DEG (Diethylene Glycol) in cough syrup which killed 66 children in Gambia had caused the death of 12 children in Jammu in 2020, 33 in Delhi-1998, 14 in Mumbai-1986 & 14 in Chennai- 1973. The company responsible for Gambia tragedy was a repeat offender in India. pic.twitter.com/BBVdnCr34E
— Shuja ul haq (@ShujaUH) October 8, 2022
Maiden Pharmaceuticals in India under scanner
The WHO on Wednesday issued an alert over four cough and cold syrups made by Maiden Pharmaceuticals in India over possible links to the deaths.
Laboratory testing had found unacceptable levels of potentially life-threatening contaminants, the WHO said, adding that the products may have been distributed beyond the West African country.
Gambian health authorities had on September 23 ordered a recall of all medicines containing paracetamol or promethazine syrup.
Barrow announced a raft of measures to avoid future tragedies, including the creation of "a quality control national laboratory for drugs and food safety".
He also promised to update the nation's drugs-related laws to ensure regulation could prevent any such incidents in the future.
He praised the work of the Health Ministry in preventing further deaths.
He said the outbreak was "now under control, with only two cases reported in the last two weeks".
Copyright © 2024 TRT World.